BlackRock Science and Technology Trust
BST · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.52 | -0.03 | 0.00 | -0.15 |
| FCF Yield | 7.43% | -3.04% | 4.84% | -1.93% |
| EV / EBITDA | 4.65 | 3.92 | -1.40 | 11.78 |
| Quality | ||||
| ROIC | 19.61% | 23.85% | -67.69% | 8.03% |
| Gross Margin | 100.00% | 79.28% | 77.24% | 90.03% |
| Cash Conversion Ratio | 0.35 | -0.12 | -0.07 | -0.23 |
| Growth | ||||
| Revenue 3-Year CAGR | 70.24% | -28.85% | 57.53% | 24.44% |
| Free Cash Flow Growth | 373.98% | -177.58% | 243.27% | 62.95% |
| Safety | ||||
| Net Debt / EBITDA | -0.00 | 0.02 | 0.00 | -0.00 |
| Interest Coverage | 77,771.91 | 19,934.94 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.21 | -36.33 | -12.93 | -272.82 |